Dr. Muhammad Asaduzzaman is a Commonwealth scholar who completed his PhD in Clinical Medicine Research from the Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, UK in 2016. Before doing his PhD, he obtained his bachelor (B. Pharm.) degree in Pharmacy and master (M. Pharm.) degree in Clinical Pharmacy and Pharmacology, both from University of Dhaka, Bangladesh. In his PhD project, he evaluated drug resistance markers in breast cancer in respect of their roles in stemness and epithelial-to-mesenchymal transitions. His research interests are focused on understanding the molecular mechanisms of chemotherapy resistance in cancer using in vitro cell line models. Previously, he was involved in various international collaborative research projects funded by British Council. One of the projects was a British Council funded INSPIRE project that was jointly conducted as a tripartite collaboration among University of Nottingham, UK, University of Dundee, UK and University of Dhaka, Bangladesh. Currently, he is serving as an assistant professor in the Department of Clinical Pharmacy and Pharmacology, University of Dhaka, Bangladesh. He is involved in collaborative research project between his home institute and Imperial College London. He is a member of British Association for Cancer Research (BACR) and a member as well as an ambassador of European Association for Cancer Research (EACR). He has published a good number of research articles in various International scientific journals. He is also an author of a book and a co-author of four books, which include the outcome of various research projects.

Study of drug resistance mechanism at the molecular level and identifying potential biomarkers related to chemotherapy resistance, cancer stemness and epithelial to mesenchymal transition (EMT).